Blade Air Mobility, now known as Strata Critical Medical, has rebranded to focus on medical and logistics services. Shares now trade as SRTA on Nasdaq after selling their Passenger business to Joby Aviation for up to $125 million. The stock rose 17.2% on the news, with a market cap of approximately $386.4 million. Financially, Blade Air reported strong second-quarter results, with revenue of $70.8 million and growth in the Medical segment. Analysts project a strong future for the company, with a consensus rating of “Strong Buy” and an average price target of $5.83, representing a 23% potential upside.

Read more at Yahoo Finance: Is BLDE Stock a Buy as Blade Air Mobility Rebrands?